The Current Ratio as of September 2024 (TTM) for Aclaris Therapeutics, Inc. (ACRS) is 7.50

According to Aclaris Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.50. This represents a change of 30.98% compared to the average of 5.73 of the last 4 quarters.

Aclaris Therapeutics, Inc. (ACRS) Historical Current Ratio (quarterly & annually)

How has ACRS Current Ratio performed in the past?

The mean historical Current Ratio of Aclaris Therapeutics, Inc. over the last ten years is 15.26. The current 7.50 Current Ratio has changed 4.82% with respect to the historical average. Over the past ten years (40 quarters), ACRS's Current Ratio was at its highest in in the December 2015 quarter at 59.19. The Current Ratio was at its lowest in in the September 2014 quarter at 0.

Aclaris Therapeutics, Inc. (ACRS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aclaris Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aclaris Therapeutics, Inc. (ACRS) Average Current Ratio

How has ACRS Current Ratio performed in the past?

The current Current Ratio of Aclaris Therapeutics, Inc. (ACRS) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Aclaris Therapeutics, Inc. (ACRS) Current Ratio vs. Peers

How is ACRS’s Current Ratio compared to its peers?

Aclaris Therapeutics, Inc.’s Current Ratio is greater than Neogen Corporation (3.82), greater than Qiagen N.V. (1.77), greater than Olink Holding AB (publ) (5.60), greater than Syneos Health, Inc. (1.20), greater than Sotera Health Company (2.93), greater than RadNet, Inc. (2.12), greater than Myriad Genetics, Inc. (1.27), greater than Genetron Holdings Limited (1.82), greater than Biodesix, Inc. (3.28), less than Castle Biosciences, Inc. (8.12), greater than Prenetics Global Limited (2.10), greater than IQVIA Holdings Inc. (0.85), greater than Medpace Holdings, Inc. (0.88), greater than ICON Public Limited Company (1.31),

Build a custom stock screener for Aclaris Therapeutics, Inc. (ACRS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aclaris Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aclaris Therapeutics, Inc. (ACRS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aclaris Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.